This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Two weeks ago we published in our Pharmacology department an exposé of the manner in which the M. J. Breitenbach Company, for advertising purposes, had made an abstract of the official report of the Porto Rico Anemia Commission and had totally misrepresented the conclusions reached by the commission in regard to the value of a preparation which the Breitenbach Company are selling, called "pepto-mangan (Gude)." This week we publish an official statement from the Porto Rico Anemia Commission, which corroborates the statement we made two weeks ago, except in unimportant particulars. There is one sentence in the letter from members of the commission which is worth noting: Speaking of the fact that had they found the peptomanganates of superior value as blood regenerators they would have said so, they add: "As it is, we have said the contrary and wrote this company to that effect at the time we became
"SCIENTIFIC WORK MISREPRESENTED AND COMMERCIALIZED.". JAMA. 1905;XLV(15):1091. doi:10.1001/jama.1905.02510150055013
Customize your JAMA Network experience by selecting one or more topics from the list below.